| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |